Author Contributions Concept and design: Kristina Nazzicone, Ashley O'Toole Acquisition, analysis, or interpretation of data: Kristina Nazzicone, Ashley O'Toole, Michael Sidiropoulos Drafting of the manuscript: Kristina Nazzicone Critical review of the manuscript for important intellectual content: Ashley O'Toole, Michael Sidiropoulos Supervision: Ashley O'Toole References 1.Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance Program
Gigliotti L, Warshaw H, Evert A, Dawkins C, Schwartz J, Susie C, et al
Dosing schedules: Ozempic dosing typically begins at 0.25 mg weekly for four weeks (an initiation dose, not therapeutic), then increases to 0.5 mg weekly
Healthcare professionals may recommend this medicine for adults with Type 2 Diabetes
By Formulation: Injectable Pens Dominate While Oral Tablets Target Injection-Averse Cohorts Injectable pens accounted for 59.73% of 2025 revenue and are forecast to grow at a 16.87% CAGR, as once-weekly dosing sustains 72% 12-month adherence
Note: Data are from the on-treatment period
